“I Dissent”: What Works With Non-Compliant Patients?
“I Dissent”: What Works With Non-Compliant Patients?
HF21
CHFS Perspective and Case-Based Approach on the 2021 CCS / CHFS Heart Failure Guidelines Update.
Canadian Experts will share their practical tips around the implementation of CCS/CHFS guidelines into the management of your patients with heart failure.
OVERALL LEARNING OBJECTIVES
• Apply recommendations from the 2021 CCS/CHFS Guidelines Update into clinical practice. (Medical Expert, Professional)
• Assess the importance of implementing 4 key therapeutic drug classes as standard therapy for most patients with HFrEF. (Medical Expert, Professional)
• Evaluate which patients will require additional key therapies and non-pharmacological interventions based on individual clinical characteristics. (Medical Expert, Professional)
31:10
Beyond Foundational Therapy: When to Reach in the Tool Box
Beyond Foundational Therapy: When to Reach in the Tool Box
33:35
Recommendations for Initiation of SGLT2i in Patients with HF and T2D
Recommendations for Initiation of SGLT2i in Patients with HF and T2D
29:30
Is There a Right Way and a Wrong Way? Sequencing of Foundational Therapy in HFrE
Is There a Right Way and a Wrong Way? Sequencing of Foundational Therapy in HFrEF
32:12
Unfriendly Neighbors: Cardiorenal Syndrome and HF
Unfriendly Neighbors: Cardiorenal Syndrome and HF
